Serenova A/S: Financial statements 2014
CVR: 30532228
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Serenova A/S (CVR 30532228) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 786,000 and a net result of DKK -22,151,000. The profit margin was -2,818.2%. Equity in the 2014 report amounted to DKK 33,685,000. The solvency ratio was 54.1%.
- Revenue
- DKK 786,000
- Profit/Loss
- DKK -22,151,000
- Equity
- DKK 33,685,000
- Total Assets
- DKK 62,299,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 786 t. | - | -22.2 mio. | 33.7 mio. | - |
| 2012 | - | -77 t. | -333 t. | 10.3 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Serenova A/S has published its annual report for 2013.
As of April 22, 2014, Poul Tørring has joined the board of directors of Serenova A/S.
As of April 22, 2014, Karin Verland has joined the board of directors of Serenova A/S.
As of April 22, 2014, Tone Bjørnov has joined the board of directors of Serenova A/S.
As of April 22, 2014, Margareta Helena Nordin Rudberg has joined the board of directors of Serenova A/S.
As of April 22, 2014, Hans Ole Svendsen has left the board of directors of Serenova A/S.
As of April 2, 2014, Søren Bech Justesen is registered as økonomidirektør of Serenova A/S.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.